New biomarker 'bim' could enable smarter treatment for melanoma patients

Over the past few years, checkpoint blockade immunotherapies have revolutionized cancer treatment and helped many patients who were previously considered untreatable. Now, new discoveries could help make these and other immunotherapies even more transformative for patients.